These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20097954)

  • 1. Carboxymethylated tetrahydropyridoindoles as aldose reductase inhibitors: in vitro selectivity study in intact rat erythrocytes in relation to glycolytic pathway.
    Juskova M; Snirc V; Gajdosikova A; Gajdosik A; Krizanova L; Stefek M
    Gen Physiol Biophys; 2009 Dec; 28(4):325-30. PubMed ID: 20097954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (2-Benzyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-8-yl)-acetic acid: an aldose reductase inhibitor and antioxidant of zwitterionic nature.
    Stefek M; Tsantili-Kakoulidou A; Milackova I; Juskova M; Snirc V; Triantos N
    Bioorg Med Chem; 2011 Dec; 19(23):7181-5. PubMed ID: 22037047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modeling.
    Stefek M; Snirc V; Djoubissie PO; Majekova M; Demopoulos V; Rackova L; Bezakova Z; Karasu C; Carbone V; El-Kabbani O
    Bioorg Med Chem; 2008 May; 16(9):4908-20. PubMed ID: 18395454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of carboxymethylated pyridoindoles on free radical-induced haemolysis of rat erythrocytes in vitro.
    Juskova M; Snirc V; Krizanova L; Stefek M
    Acta Biochim Pol; 2010; 57(2):153-6. PubMed ID: 20066176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure optimization of tetrahydropyridoindole-based aldose reductase inhibitors improved their efficacy and selectivity.
    Majekova M; Ballekova J; Prnova M; Stefek M
    Bioorg Med Chem; 2017 Dec; 25(24):6353-6360. PubMed ID: 29074349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel zwitterionic inhibitor of aldose reductase interferes with polyol pathway in ex vivo and in vivo models of diabetic complications.
    Karasova MJ; Prnova MS; Stefek M
    Pharmazie; 2014 Oct; 69(10):747-51. PubMed ID: 25985564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro inhibition of lens aldose reductase by (2-benzyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole-8-yl)-acetic acid in enzyme preparations isolated from diabetic rats.
    Djoubissie PO; Snirc V; Sotnikova R; Zurova J; Kyselova Z; Skalska S; Gajdosik A; Javorkova V; Vlkovicova J; Vrbjar N; Stefek M
    Gen Physiol Biophys; 2006 Dec; 25(4):415-25. PubMed ID: 17356233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidant action of 3-mercapto-5H-1,2,4-triazino[5,6-b]indole-5-acetic acid, an efficient aldose reductase inhibitor, in a 1,1'-diphenyl-2-picrylhydrazyl assay and in the cellular system of isolated erythrocytes exposed to tert-butyl hydroperoxide.
    Prnova MS; Ballekova J; Majekova M; Stefek M
    Redox Rep; 2015; 20(6):282-8. PubMed ID: 26066740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel carboxymethylated mercaptotriazinoindole inhibitor of aldose reductase interferes with the polyol pathway in streptozotocin-induced diabetic rats.
    Soltesova Prnova M; Ballekova J; Gajdosikova A; Gajdosik A; Stefek M
    Physiol Res; 2015; 64(4):587-91. PubMed ID: 26291727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Chloro-1,4-naphthoquinone derivative of quercetin as an inhibitor of aldose reductase and anti-inflammatory agent.
    Milackova I; Prnova MS; Majekova M; Sotnikova R; Stasko M; Kovacikova L; Banerjee S; Veverka M; Stefek M
    J Enzyme Inhib Med Chem; 2015 Feb; 30(1):107-13. PubMed ID: 24666303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective Effects of Novel Substituted Triazinoindole Inhibitors of Aldose Reductase and Epalrestat in Neuron-like PC12 Cells and BV2 Rodent Microglial Cells Exposed to Toxic Models of Oxidative Stress: Comparison with the Pyridoindole Antioxidant Stobadine.
    Elmazoglu Z; Prnova MS; Stefek M; Ceylan AF; Aschner M; Rangel-López E; Santamaria A; Karasu C
    Neurotox Res; 2021 Jun; 39(3):588-597. PubMed ID: 33713301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substituted derivatives of indole acetic acid as aldose reductase inhibitors with antioxidant activity: structure-activity relationship.
    Juskova M; Majekova M; Demopoulos V; Stefek M
    Gen Physiol Biophys; 2011 Dec; 30(4):342-9. PubMed ID: 22131315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Novel Indole-Based Bifunctional Aldose Reductase Inhibitors/Antioxidants as Promising Drugs for the Treatment of Diabetic Complications.
    Kovacikova L; Prnova MS; Majekova M; Bohac A; Karasu C; Stefek M
    Molecules; 2021 May; 26(10):. PubMed ID: 34066081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel aldose reductase inhibitors based on carboxymethylated mercaptotriazinoindole scaffold.
    Stefek M; Soltesova Prnova M; Majekova M; Rechlin C; Heine A; Klebe G
    J Med Chem; 2015 Mar; 58(6):2649-57. PubMed ID: 25695864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triglyceride-lowering effect of the aldose reductase inhibitor cemtirestat-another factor that may contribute to attenuation of symptoms of peripheral neuropathy in STZ-diabetic rats.
    Prnova MS; Kovacikova L; Svik K; Bezek S; Elmazoğlu Z; Karasu C; Stefek M
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):651-661. PubMed ID: 31802170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of rhetsinine isolated from Evodia rutaecarpa on aldose reductase activity.
    Kato A; Yasuko H; Goto H; Hollinshead J; Nash RJ; Adachi I
    Phytomedicine; 2009 Mar; 16(2-3):258-61. PubMed ID: 17498942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
    Saraswat M; Muthenna P; Suryanarayana P; Petrash JM; Reddy GB
    Asia Pac J Clin Nutr; 2008; 17(4):558-65. PubMed ID: 19114390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Aldose Reductase in Polyol Pathway: An Emerging Pharmacological Target in Diabetic Complications and Associated Morbidities.
    Gupta JK
    Curr Pharm Biotechnol; 2024; 25(9):1073-1081. PubMed ID: 37649296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [5-(Benzyloxy)-1H-indol-1-yl]acetic acid, an aldose reductase inhibitor and PPARγ ligand.
    Soltesova Prnova M; Majekova M; Milackova I; Díez-Dacal B; Pérez-Sala D; Ceyhan MS; Banerjee S; Stefek M
    Acta Biochim Pol; 2015; 62(3):523-8. PubMed ID: 26345091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Novel Oxotriazinoindole Inhibitors of Aldose Reductase: Isosteric Sulfur/Oxygen Replacement in the Thioxotriazinoindole Cemtirestat Markedly Improved Inhibition Selectivity.
    Hlaváč M; Kováčiková L; Prnová MŠ; Šramel P; Addová G; Májeková M; Hanquet G; Boháč A; Štefek M
    J Med Chem; 2020 Jan; 63(1):369-381. PubMed ID: 31820975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.